The optimal regulation mode of Bcl-2 apoptotic switch revealed by bistability analysis

In most cell types, apoptosis occurs by the mitochondrial outer membrane permeability (MOMP)-mediated pathway, which is controlled by Bcl-2 family proteins (often referred to as Bcl-2 apoptotic switch). These proteins, which display a range of bioactivities, can be divided into four types: effectors, inhibitors, activators and sensitizers. Although the complex interactions among Bcl-2 family members have been studied intensively, a unifying hypothesis for the mechanism they use to regulate MOMP remains elusive. The bistable behaviors are often used to explain the all-or-none decisions of apoptosis. Here, we attempt to reveal the optimal interaction mode by comparing the bistable performances of three different modes (direct activation, indirect activation, and unified mode) proposed by biologists. Using the method that combines mathematical analysis and numerical simulation, we discover that bistability can only emerge from the unified mode when proteins synthesis and degradation are considered, which is in favor of it as an optimal regulation mode of Bcl-2 apoptotic switch. The parameter sensitivity analysis for the unified mode further consolidates this view. Moreover, two-parameter bifurcation analysis suggests that the sensitizers lower the threshold of activation of Bax, but have a negative influence on the width of the bistability region. Our study may provide mechanistic insights into the heterogeneity of tumor cells and the efficiency of BH3 mimetic-mediated killing of cancer cells, and suggest that a combination treatment might be required to overcome apoptosis resistance in the Bcl-2 family targeted therapies.

[1]  Frank Allgöwer,et al.  Death wins against life in a spatially extended model of the caspase-3/8 feedback loop , 2012, Biosyst..

[2]  Erinna F. Lee,et al.  Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis , 2013, Cell.

[3]  Jianwei Shuai,et al.  Synonymous mutations in oncogenesis and apoptosis versus survival unveiled by network modeling , 2016, Oncotarget.

[4]  Rachel T. Uren,et al.  Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak , 2007, The Journal of cell biology.

[5]  David L. Vaux,et al.  Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies , 2016, Nature Reviews Cancer.

[6]  D. Green,et al.  To Be or Not to Be? How Selective Autophagy and Cell Death Govern Cell Fate , 2014, Cell.

[7]  Xu Luo,et al.  Bax/Bak activation in the absence of Bid, Bim, Puma, and p53 , 2016, Cell Death and Disease.

[8]  Tingzhe Sun,et al.  Evaluating bistability of Bax activation switch , 2010, FEBS letters.

[9]  Arthur E. Johnson,et al.  Bax Forms an Oligomer via Separate, Yet Interdependent, Surfaces* , 2010, The Journal of Biological Chemistry.

[10]  Jianwei Shuai,et al.  Alzheimer's disease via enhanced calcium signaling caused by the decrease of endoplasmic reticulum-mitochondrial distance. , 2016, Medical hypotheses.

[11]  N. Tjandra,et al.  BAX Activation is Initiated at a Novel Interaction Site , 2008, Nature.

[12]  S. Korsmeyer,et al.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. , 2002, Cancer cell.

[13]  David W Andrews,et al.  Auto-activation of the Apoptosis Protein Bax Increases Mitochondrial Membrane Permeability and Is Inhibited by Bcl-2* , 2006, Journal of Biological Chemistry.

[14]  J. Chipuk,et al.  Death upon a kiss: mitochondrial outer membrane composition and organelle communication govern sensitivity to BAK/BAX-dependent apoptosis. , 2014, Chemistry & biology.

[15]  A. García-Sáez,et al.  Proapoptotic Bax and Bak Proteins Form Stable Protein-permeable Pores of Tunable Size , 2013, The Journal of Biological Chemistry.

[16]  Peter E. Czabotar,et al.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy , 2013, Nature Reviews Molecular Cell Biology.

[17]  Chengyu Liang,et al.  Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX , 2011, Cell Research.

[18]  Brian Ingalls,et al.  Sensitivity analysis: from model parameters to system behaviour. , 2008, Essays in biochemistry.

[19]  Nils Blüthgen,et al.  Mathematical Modeling Identifies Inhibitors of Apoptosis as Mediators of Positive Feedback and Bistability , 2006, PLoS Comput. Biol..

[20]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.

[21]  D. Green,et al.  The Pathophysiology of Mitochondrial Cell Death , 2004, Science.

[22]  Erinna F. Lee,et al.  Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak , 2007, Science.

[23]  D. Green,et al.  A unified model of mammalian BCL-2 protein family interactions at the mitochondria. , 2011, Molecular cell.

[24]  Wei Zhang,et al.  Robustness analysis identifies the plausible model of the Bcl‐2 apoptotic switch , 2007, FEBS letters.

[25]  P. Johnston,et al.  Dynamical Systems Analysis of Mitochondrial BAK Activation Kinetics Predicts Resistance to BH3 Domains , 2008, PloS one.

[26]  Tom'avs Tok'ar,et al.  Computational study of the mechanism of Bcl-2 apoptotic switch , 2011, 1110.5225.

[27]  Peter K. Sorger,et al.  Measuring and Modeling Apoptosis in Single Cells , 2011, Cell.

[28]  Hal L. Smith,et al.  Monotone Dynamical Systems: An Introduction To The Theory Of Competitive And Cooperative Systems (Mathematical Surveys And Monographs) By Hal L. Smith , 1995 .

[29]  D. Green,et al.  Mitochondria and cell death: outer membrane permeabilization and beyond , 2010, Nature Reviews Molecular Cell Biology.

[30]  G B Ermentrout,et al.  Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. , 2006, Biophysical journal.

[31]  M. Stumpf,et al.  Systems biology (un)certainties , 2015, Science.

[32]  David C Samuels,et al.  The Bcl-2-associated death promoter (BAD) lowers the threshold at which the Bcl-2-interacting domain death agonist (BID) triggers mitochondria disintegration. , 2011, Journal of theoretical biology.

[33]  G. Ichim,et al.  A fate worse than death: apoptosis as an oncogenic process , 2016, Nature Reviews Cancer.

[34]  R. Milo,et al.  Dynamic Proteomics of Individual Cancer Cells in Response to a Drug , 2008, Science.

[35]  Eduardo Sontag,et al.  Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Philippe Juin,et al.  Decoding and unlocking the BCL-2 dependency of cancer cells , 2013, Nature Reviews Cancer.

[37]  Jeremy L. Muhlich,et al.  Properties of cell death models calibrated and compared using Bayesian approaches , 2013, Molecular systems biology.

[38]  Uri Alon,et al.  Proteome Half-Life Dynamics in Living Human Cells , 2011, Science.

[39]  Jochen H M Prehn,et al.  The indirect activation model of mitochondrial outer membrane permeabilisation (MOMP) initiation requires a trade-off between robustness in the absence of and sensitivity in the presence of stress. , 2013, Molecular bioSystems.

[40]  Tomomi Gotoh,et al.  ER Stress Triggers Apoptosis by Activating BH3-Only Protein Bim , 2007, Cell.

[41]  Tingzhe Sun,et al.  Two Independent Positive Feedbacks and Bistability in the Bcl-2 Apoptotic Switch , 2008, PloS one.

[42]  Javier Naval,et al.  Farnesyltransferase Inhibitor BMS-214662 Induces Apoptosis in Myeloma Cells through PUMA Up-Regulation, Bax and Bak Activation, and Mcl-1 Elimination , 2005, Molecular Pharmacology.

[43]  Brian J. Smith,et al.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. , 2005, Molecular cell.

[44]  Jochen H M Prehn,et al.  Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy. , 2013, Cancer research.

[45]  D. Green,et al.  Mitochondrial regulation of cell death. , 2013, Cold Spring Harbor perspectives in biology.

[46]  Klas Blomgren,et al.  Mitochondrial membrane permeabilization in neuronal injury , 2009, Nature Reviews Neuroscience.

[47]  L. Attardi,et al.  The role of apoptosis in cancer development and treatment response , 2005, Nature Reviews Cancer.

[48]  Douglas A Lauffenburger,et al.  Effects of Bcl-2 Levels on Fas Signaling-Induced Caspase-3 Activation: Molecular Genetic Tests of Computational Model Predictions1 , 2005, The Journal of Immunology.

[49]  S. Willis,et al.  Life in the balance: how BH3-only proteins induce apoptosis. , 2005, Current opinion in cell biology.

[50]  Rui Wang,et al.  Modeling of the role of a Bax-activation switch in the mitochondrial apoptosis decision. , 2007, Biophysical journal.

[51]  A. Letai,et al.  Mitochondria-Judges and Executioners of Cell Death Sentences. , 2016, Molecular cell.

[52]  B. Kholodenko,et al.  The dynamic control of signal transduction networks in cancer cells , 2015, Nature Reviews Cancer.

[53]  A. Strasser,et al.  The BCL-2 protein family, BH3-mimetics and cancer therapy , 2015, Cell Death and Differentiation.

[54]  James J. Hsieh,et al.  An Interconnected Hierarchical Model of Cell Death Regulation by the BCL-2 Family , 2015, Nature Cell Biology.

[55]  D. Lauffenburger,et al.  Modeling a Snap-Action, Variable-Delay Switch Controlling Extrinsic Cell Death , 2008, PLoS biology.

[56]  S. Cory,et al.  The Bcl-2 apoptotic switch in cancer development and therapy , 2007, Oncogene.

[57]  F. Allgöwer,et al.  Bistability Analyses of a Caspase Activation Model for Receptor-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[58]  Frank Allgöwer,et al.  Steady state and (bi-) stability evaluation of simple protease signalling networks , 2007, Biosyst..

[59]  Jian Yu,et al.  Targeting Bax interaction sites reveals that only homo-oligomerization sites are essential for its activation , 2013, Cell Death and Differentiation.

[60]  Jianfeng Pei,et al.  Mutation-induced protein interaction kinetics changes affect apoptotic network dynamic properties and facilitate oncogenesis , 2015, Proceedings of the National Academy of Sciences.

[61]  S. Hess,et al.  Chlamydia Inhibit Host Cell Apoptosis by Degradation of Proapoptotic BH3-only Proteins , 2004, The Journal of experimental medicine.

[62]  Osamu Takeuchi,et al.  BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program , 2010, Science.

[63]  Seamus J. Martin,et al.  Opening the Cellular Poison Cabinet , 2010, Science.